QurientPress Release


 

Press Release

  • 121
  • 120
  • 119
    • Qurient Announces Dosing of First Patient in Q702 in Combina…

      Article Source : Business Wire
      Link : https://www.businesswire.com/news/home/20230202005011/en/Qurient-Announces-Dosing-of-First-Patient-in-Q702-in-Combination-with-KEYTRUDA%C2%AE-in-a-Phase-1b2-Clinical-Study-for-the-Treatment-of-Patients-with-Solid-Tumors

      Date
      2023-01-30
      Author
      QURIENT
  • 118
  • 117
  • 116
  • 115
  • 114
  • 113
  • 112
  • 111
    • Qurient Announces Collaboration Agreement with MSD to Evalua…

      Article Source : Business Wire
      Link : https://www.businesswire.com/news/home/20220914005974/en/Qurient-Announces-Collaboration-Agreement-with-MSD-to-Evaluate-Selective-CDK7-Inhibitor-Q901-in-Combination-With-KEYTRUDA%C2%AE-pembrolizumab

      Date
      2022-09-14
      Author
      QURIENT
  • 110
  • 109
  • 108
  • information for download file